射血分数保留的心力衰竭与心房颤动:诊断挑战与治疗机遇
本文综述了心房颤动(AF)对射血分数保留的心力衰竭(HFpEF)在疾病检测、症状负担和预后方面的影响,并回顾了可能降低AF风险、改善HFpEF患者症状、功能与生存的药物及介入治疗。AF使HFpEF的诊断和管理复杂化。
要点
- AF在HFpEF中常见,并显著影响其诊断、症状与预后。
- AF使HFpEF的诊断和管理复杂化。
- 部分药物及介入治疗可能降低AF风险并改善HFpEF结局。
核心结论
- AF对HFpEF的疾病检测、症状负担和预后有重要影响,并使诊断和管理复杂化。
研究设计与样本
- 综述,检索范围未在摘要中报告。
主要发现
- AF在HFpEF中常见,并对疾病检测、症状负担和预后有重要临床意义。
临床怎么用
- 在HFpEF管理中应关注AF对诊断、症状和预后的影响。
- 可考虑药物及介入治疗以降低AF风险并改善HFpEF患者症状、功能与生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Heart failure with preserved ejection fraction (HFpEF) is a syndrome characterised by cardiac and non-cardiac physiologic disturbances, commonly underpinned by cardiometabolic abnormalities, which culminate in elevated left ventricular filling pressures and progressive symptoms of exercise intolerance. Arrhythmias, particularly atrial fibrillation (AF), are common in HFpEF and have important clinical implications. AF complicates the diagnosis and management of HFpEF. In this review, we synthesise the impact of AF on disease detection, symptom burden and prognosis and HFpEF treatment. Furthermore, we review pharmacological and interventional therapies that may mitigate the risk of AF and improve how patients with HFpEF feel, function and survive.
引用
- Verelst, Witte, Ahmed, et al. Atrial fibrillation and heart failure with preserved ejection fraction: diagnostic challenges and therapeutic opportunities. Heart. 2026. PMID: 41644282. doi:10.1136/heartjnl-2025-326954
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。